One study found that the serum levels of Apelin-13 and 25-hydroxyvitamin D3 (25(OH)D3) are significantly lower in patients with osteoporosis than in healthy people (88), suggesting that Apelin-13 might be associated with bone metabolism. This evidence concerns the gene APLN and osteoporosis.